CW February 2003
Volume 12Issue Number 2 February 2003 ISSN 10593802 ATAC Clinical Trial ResultsA continuing follow-up of ATAC, the largest breast cancer clinical trial, shows that anastrozole?s (Arimidex) significant improvements in recurrence-free survival and better tolerability as compared with tamoxifen (Nolvadex) are maintained with longer treatment.
Go to Previous Page Go to Next Page Source & Additional Reading 25th Annual San Antonio Breast Cancer Symposium. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
